QSAM Biosciences, Inc.·5

Feb 16, 4:01 PM ET

WHITNEY SCOTT W. 5

5 · QSAM Biosciences, Inc. · Filed Feb 16, 2021

Insider Transaction Report

Form 5
Period: 2020-12-31
Transactions
  • Conversion

    COMMON STOCK

    2020-09-30$0.22/sh+705,176$155,139705,176 total
  • Award

    COMMON STOCK

    2020-12-17$0.22/sh+96,782$21,292801,958 total
  • Award

    Options to buy common stock

    2020-01-06+40,00040,000 total
    Exercise: $0.50From: 2020-01-06Exp: 2030-01-06Common Stock (40,000 underlying)
Holdings
  • Options to buy common stock

    Exercise: $0.50From: 2018-12-01Exp: 2028-12-01COMMON STOCK (48,000 underlying)
Footnotes (2)
  • [F1]Shares acquired pursuant to conversion of promissory note at a conversion price of $0.22 per share.
  • [F2]Shares acquired pursuant to conversion of accured director fees at a conversion price of $0.22 per share.

Documents

1 file
  • 5
    ownership.xmlPrimary